Versant Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Versant Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10	Closed	-$1.16K	–	2047
2023 Q3	$1.16K	Hold	10	–	–	﹤0.01%	1487
2023 Q2	$1.03K	Hold	10	–	–	﹤0.01%	1591
2023 Q1	$1.09K	Hold	10	–	–	﹤0.01%	1417
2022 Q4	$1.14K	Hold	10	–	–	﹤0.01%	1271
2022 Q3	$1K	Hold	10	–	–	﹤0.01%	1396
2022 Q2	$1K	Hold	10	–	–	﹤0.01%	1416
2022 Q1	$1K	Hold	10	–	–	﹤0.01%	1429
2021 Q4	$1K	Hold	10	–	–	﹤0.01%	1408
2021 Q3	$1K	Hold	10	–	–	﹤0.01%	1421
2021 Q2	$1K	Hold	10	–	–	﹤0.01%	1419
2021 Q1	$1K	Hold	10	–	–	﹤0.01%	1495
2020 Q4	$0	Hold	10	–	–	﹤0.01%	1634
2020 Q3	$0	Hold	10	–	–	﹤0.01%	1614
2020 Q2	$0	Hold	10	–	–	﹤0.01%	1684
2020 Q1	$0	Hold	10	–	–	﹤0.01%	1869
2019 Q4	$0	Hold	10	–	–	﹤0.01%	1732
2019 Q3	$0	Hold	10	–	–	﹤0.01%	1739
2019 Q2	$0	Sell	10 -51	-84%	-$1.29K	﹤0.01%	1875
2019 Q1	$1K	Hold	61	–	–	﹤0.01%	1530
2018 Q4	$1K	Hold	61	–	–	﹤0.01%	1441
2018 Q3	$1K	Hold	61	–	–	﹤0.01%	1486
2018 Q2	$1K	Sell	61 -2	-3%	-$30	﹤0.01%	1475
2018 Q1	$0	Buy	63 +18	+40%	+$266	﹤0.01%	1747
2017 Q4	$0	Hold	45	–	–	﹤0.01%	1711
2017 Q3	$0	Buy	+45	New	+$572	﹤0.01%	1640
2017 Q2	–	Sell	-45	Closed	-$560	–	1613
2017 Q1	$0	Buy	+45	New	+$729	﹤0.01%	1602

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Versant Capital Management's HZNP Position: Q4 2023 in Review

Versant Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 10 shares — an estimated $1.16K sold.

Versant Capital Management first reported a position in HZNP in Q1 2017 and held it in 26 quarters. The position peaked at $1.16K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Versant Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Versant Capital Management sold 10 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.16K.
Versant Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2017 and held it in 26 quarters.
Versant Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.16K in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Versant Capital Management's 13F filing for Q4 2023, filed 8 Jan 2024.